Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT.

Feasibility assessment of yttrium-90 liver radioembolization imaging using amplitude-based gated PET/CT.

Nucl Med Commun. 2018 Jan 18;:

Authors: Osborne DR, Acuff SN, Neveu ML, Syed M, Kaman AD, Fu Y

Abstract
PURPOSE: The usage of PET/computed tomography (CT) to monitor hepatocellular carcinoma patients following yttrium-90 (Y) radioembolization has increased. Respiratory motion causes liver movement, which can be corrected using gating techniques at the expense of added noise. This work examines the use of amplitude-based gating on Y-PET/CT and its potential impact on diagnostic integrity.
PATIENTS AND METHODS: Patients were imaged using PET/CT following Y radioembolization. A respiratory band was used to collect respiratory cycle data. Patient data were processed as both standard and motion-corrected images. Regions of interest were drawn and compared using three methods. Activity concentrations were calculated and converted into dose estimates using previously determined and published scaling factors. Diagnostic assessments were performed using a binary scale created from published Y-PET/CT image interpretation guidelines.
RESULTS: Estimates of radiation dose were increased (P<0.05) when using amplitude-gating methods with Y PET/CT imaging. Motion-corrected images show increased noise, but the diagnostic determination of success, using the Kao criteria, did not change between static and motion-corrected data.
CONCLUSION: Amplitude-gated PET/CT following Y radioembolization is feasible and may improve Y dose estimates while maintaining diagnostic assessment integrity.

PMID: 29351124 [PubMed - as supplied by publisher]

http://ift.tt/2DxLYBs